Skip to main content
PolicySpeak
← All files
HAL

Haleon

Company · United Kingdom · EU Transparency Register 292566647414-46

1
position filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1048 companies & groups on this site, they rank #832 by legislative files engaged — a count of participation, not a measure of influence.

1.3
declared lobbying FTE
self-declared
€600K+
declared costs / yr (floor)
3
EP accreditations
as declared to the register
2022
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).

Register category
Companies & groups
Head office
Weybridge, United kingdom
EU office
Brussels

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Haleon in PolicySpeak: request access →

Work at Haleon? so we know who speaks for it.

Follow the file Haleon engages with

One email on Tuesdays when a new position is filed on this file, from Haleon or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Haleon filed 1 position on 6 Nov 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Medicinal products for human usefiled 6 Nov 2023PDFsource

Haleon, a global leader in consumer health with a purpose to deliver better everyday health with humanity, welcomes the overall objectives of the European Commissions proposal for a revision of the EUs General Pharmaceutical Legislation. We also acknowledge and commend the patient-centred approach that the European Commission has chosen to adopt in its Pharmaceutical Strategy.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Haleon next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Haleon’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.